Real-time enrollment status for this recurrent multiple myeloma clinical trial
Current Status
Recruiting
Checked: September 25, 2026 at 5:44 AM UTC
| NCT Number | NCT06948084 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 80 participants |
| Active Locations | 14 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 24, 2026 (Yesterday) |
As of September 25, 2026: Clinical trial NCT06948084 is currently recruiting participants. This phase2 study for recurrent multiple myeloma is actively seeking new participants at 14 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06948084 is actively recruiting participants as of September 25, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06948084 was last updated Yesterday (September 24, 2026). HelloStudys verifies this status automatically.